The novel treatment of the medication represents a significant development in the care of the condition. Distinct from existing medications, tirzepatide affects two pathways – the GLP-1 hormone and GIP – providing https://tirzepatide-peptide717309.mdkblog.com/48247602/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment